Literature DB >> 35380007

Recording an isoelectric interval as an endpoint of left bundle branch pacing with continuous paced intracardiac electrogram monitoring.

Hao Wu1, Longfu Jiang2, Jiabo Shen1.   

Abstract

BACKGROUND: The present study aimed to evaluate the feasibility and safety of the novel left bundle branch pacing (LBBP) procedure that uses isoelectric interval as an endpoint for lead implantation.
METHODS: A total of 41 patients with indications for pacing were enrolled. All patients underwent a novel LBBP procedure guided by recording an isoelectric interval as an endpoint for lead implantation. The procedural details and electrophysiological characteristics were then analyzed.
RESULTS: A total of 38/41 (92.7%) cases were confirmed of left bundle branch (LBB) capture. An isoelectric interval was observed in 36/41 cases (87.8%). A total of 36/41 (87.8%) cases with LBB potential were observed. The mean unipolar LBBP threshold at the implant was 0.5 ± 0.2 V. The mean sensed amplitude of the R wave and the pacing impedance at the implant were 12.9 ± 5.0 mV and 723.5 ± 117.1 Ω. During the final threshold testing, a transition from non-selective to selective LBBP (S-LBBP) was demonstrated in 26 patients. A transition from non-selective LBBP (NS-LBBP) to left ventricular septal myocardial capture was observed in 12 patients.
CONCLUSION: Using an isoelectric interval as an endpoint to guide the LBBP was feasible in a high proportion of captured LBB cases.

Entities:  

Keywords:  John Jiang’s connecting cable; conduction system pacing; intracardiac electrogram; isoelectric interval; left bundle branch pacing

Mesh:

Year:  2022        PMID: 35380007     DOI: 10.33963/KP.a2022.0094

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.710


  1 in total

1.  Characteristics of intracardiac electrogram of the interventricular septum in the left bundle branch pacing.

Authors:  Xiaojie Cai; Longfu Jiang; Shanshan Zhuo; Hao Wu
Journal:  BMC Cardiovasc Disord       Date:  2022-06-17       Impact factor: 2.174

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.